Mutations in the BCR-ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis

Ítems similars

• Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
  per: Chandrasekhar, Chodimella, et al.
  Publicat: (2019)
• Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
  per: McCarron, Sarah L., et al.
  Publicat: (2013)
• Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia
  per: Leder, Kevin, et al.
  Publicat: (2011)
• Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
  per: Eşkazan, Ahmet Emre, et al.
  Publicat: (2013)
• Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case
  per: Al-Achkar, Walid, et al.
  Publicat: (2014)